Autoimmune hemolytic anemia

May 05, 2020

Rigel Reports First Quarter 2020 Financial Results and Provides Business Update

Feb 27, 2020

Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Jan 13, 2020

Rigel Pharmaceuticals Provides Business Update

Dec 17, 2019

Rigel Announces Chief Commercial Officer Transition

Nov 07, 2019

Cold Agglutinin Disease (CAD) Epidemiology Report 2019: Total Prevalent Cases the 10EM was Found to be 29,077 in 2017 - Forecast to 2028

Oct 16, 2019

Rigel to Host Investor and Analyst Call on October 23, 2019

Aug 06, 2019

Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update

Jun 13, 2019

Rigel to Present Two Posters Highlighting Fostamatinib at the 24 Congress of the European Hematology Association (EHA)

May 16, 2019

Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia

Jan 07, 2019

Rigel Pharmaceuticals Provides Business Update

Nov 06, 2018

Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update

Nov 01, 2018

Rigel to Present Data on Fostamatinib in Three Presentations at the 60th American Society of Hematology Annual Meeting & Exposition

Sep 27, 2018

Rigel to Host Investor & Analyst Day in New York City on October 4, 2018

Jun 12, 2018

Rigel To Present Phase 2 Results for Fostamatinib in Autoimmune Hemolytic Anemia at EHA